Format

Send to

Choose Destination
Oral Maxillofac Surg Clin North Am. 2018 Aug;30(3):343-349. doi: 10.1016/j.coms.2018.04.009. Epub 2018 Jun 1.

Injectable Agents Versus Surgery for Recurrent Temporomandibular Joint Dislocation.

Author information

1
Department of Oral and Maxillofacial Surgery, Virginia Commonwealth University, 520 North 12th Street, Wood Building Room 311C, Richmond, VA 23298, USA.
2
Department of Oral and Maxillofacial Surgery, Virginia Commonwealth University, 520 North 12th Street, Wood Building Room 311C, Richmond, VA 23298, USA. Electronic address: dmlaskin@vcu.edu.

Abstract

Recurrent temporomandibular joint dislocation (TMJD) is a distressing entity to the patient and a therapeutic challenge to the treating provider. Absence of high-level evidence in literature among currently available treatment options creates a lack of consistency in management. This article reviews the current literature on common injectable agents used and the open surgical techniques. Based on the findings, an injectable agent is the initial treatment of choice for recurrent TMJD, with capsulorraphy and eminectomy being used in nonresponding patients.

KEYWORDS:

Autologous blood injection; Eminectomy; Sclerosing agents; Subluxation; Temporomandibular joint dislocation

PMID:
29866448
DOI:
10.1016/j.coms.2018.04.009
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center